CRISPR/Cas9 genome-wide gRNA library for target identification

被引：0
|
作者：
Tedesco, Donato
Diehl, Paul
Makhanov, Mikhail
Baron, Sylvain
Suchkov, Dmitry
Frangou, Costa
Chenchik, Alex
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4354
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4354
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Genome-wide CRISPR/Cas9 screen for the identification of novel YAP1/TAZ modulators
    Naujoks, Jan
    Potze, Lisette
    Anurin, Anna
    Kuehnlenz, Julia
    Lesche, Ralf
    Kamburov, Atanas
    Nevedomskaya, Ekaterina
    Steffen, Andreas
    Lange, Martin
    Nicke, Barbara
    CANCER RESEARCH, 2019, 79 (13)
  • [22] Identification of a novel key regulator of T cell activation by genome-wide CRISPR/Cas9 screening
    Wang, R.
    Zhang, L.
    Wang, W.
    Du, M.
    Bi, Y.
    Zhang, N.
    Shang, H.
    Zhang, C.
    Zhang, H.
    Cao, Y.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 26 - 26
  • [23] gRNA-transient expression system for simplified gRNA delivery in CRISPR/Cas9 genome editing
    Easmin, Farhana
    Hassan, Naim
    Sasano, Yu
    Ekino, Keisuke
    Taguchi, Hisataka
    Harashima, Satoshi
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2019, 128 (03) : 373 - 378
  • [24] Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC
    Lai Wei
    Derek Lee
    Cheuk-Ting Law
    Misty Shuo Zhang
    Jialing Shen
    Don Wai-Ching Chin
    Allen Zhang
    Felice Ho-Ching Tsang
    Ceci Lok-Sze Wong
    Irene Oi-Lin Ng
    Carmen Chak-Lui Wong
    Chun-Ming Wong
    Nature Communications, 10
  • [25] Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC
    Wei, Lai
    Lee, Derek
    Law, Cheuk-Ting
    Zhang, Misty Shuo
    Shen, Jialing
    Chin, Don Wai-Ching
    Zhang, Allen
    Tsang, Felice Ho-Ching
    Wong, Ceci Lok-Sze
    Ng, Irene Oi-Lin
    Wong, Carmen Chak-Lui
    Wong, Chun-Ming
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [26] High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
    Benjamin P. Kleinstiver
    Vikram Pattanayak
    Michelle S. Prew
    Shengdar Q. Tsai
    Nhu T. Nguyen
    Zongli Zheng
    J. Keith Joung
    Nature, 2016, 529 : 490 - 495
  • [27] A method to convert mRNA into a gRNA library for CRISPR/Cas9 editing of any organism
    Arakawa, Hiroshi
    SCIENCE ADVANCES, 2016, 2 (08):
  • [28] Defining CRISPR–Cas9 genome-wide nuclease activities with CIRCLE-seq
    Cicera R. Lazzarotto
    Nhu T. Nguyen
    Xing Tang
    Jose Malagon-Lopez
    Jimmy A. Guo
    Martin J. Aryee
    J. Keith Joung
    Shengdar Q. Tsai
    Nature Protocols, 2018, 13 : 2615 - 2642
  • [29] Establishment of a genome-wide CRISPR/Cas9 screening method for the identification of cellular factors that affect AAV production
    Huellen, F. J.
    Scheer, N.
    Seibler, J.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A36 - A36
  • [30] Identification of pathways modulating vemurafenib resistance in melanoma cells via a genome-wide CRISPR/Cas9 screen
    Goh, Corinna Jie Hui
    Wong, Jin Huei
    El Farran, Chadi
    Tan, Ban Xiong
    Coffill, Cynthia
    Loh, Yuin-Hain
    Lane, David
    Arumugam, Prakash
    G3-GENES GENOMES GENETICS, 2021, 11 (02):
12345